DHSC0041159_230 - Appendix D Long term funding for recombinant treatment
Appendix D - Document on Restricted - Policy. It refers to the following; Long term funding for recombinant treatment for haemophiliac patients. The MS(PH) announced on 19th April that further funding for the Recombinant treatment will continue.
Documents
DHSC0041159 230 Appendix D Long term funding for recombinant treatment